Three Goals That Define a Good Design | AI Learning Guide

A useful way to hold these three goals apart is to ask what each one would tell you if it failed. If target binding fails, the antibody never attaches at all — the design is simply wrong for the job. If specificity fails, it attaches, but also to a close relative of the target, which in a therapy means hitting the wrong molecule. If affinity fails, it attaches to the right molecule but lets go too easily to do any good. So they are three separate questions about the same molecule, and passing one says nothing about the others. That is also why they trade off: the changes that make a fit tighter can make it less choosy, so a real design is a balance, not a record score on any single measure.

0:00 / 0:00

Auto-play

Target binding, specificity, and affinity are the three goals that define a good antibody design. They are related but not interchangeable: a design can succeed at one and fail another.

What each goal asks, and what failing it means

Target binding asks whether the antibody attaches to the intended molecule at all. It is the first hurdle: without binding, nothing else matters, and failing here means the design is simply wrong for the job.
Specificity asks whether it attaches to the intended target rather than to similar molecules. It matters most when the target has close relatives in the same environment, and failing here can cause effects on the wrong molecule, which is a safety concern in therapy.
Affinity asks how strongly it holds on once attached. It is usually described by the dissociation constant \(K_d\), the concentration at which half the binding sites are occupied; a smaller \(K_d\) means tighter binding, and failing here means the antibody lets go too easily to be effective.

Why the three goals pull against each other

In practice the goals trade off. Tightening the fit to the target can also tighten it to a near-relative, trading specificity for affinity; loosening the fit to avoid cross-reactivity can drop affinity below what a therapeutic needs. A design is therefore a compromise across all three, not a maximization of any single one.

Because the goals are related but not interchangeable, a design that looks strong on one measure can still fail on another. Judging a design means checking all three together rather than optimizing any one of them alone.